Abiopharma

🔍 WEIGLE ROBERT K (Director)

Company: Tenon Medical, Inc. (TNON)

Report Date: 2026-01-01

Detailed Transactions and Holdings:

• Acquired 10,732 shares of Common Stock (Direct)
  Date: 2026-01-01 | Code: M | equity_swap_involved: 0 | shares_owned_after: 10,965.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 3,413 shares of Common Stock at $0.9301 per share (Direct)
  Date: 2026-01-05 | Code: F | equity_swap_involved: 0 | shares_owned_after: 7,552.00 | transaction_form_type: 4 | Footnotes: F2
• Sold 10,732 shares of Restricted Stock Units (Derivative)
  Date: 2026-01-01 | Code: M | equity_swap_involved: 0 | shares_owned_after: 10,732.00 | transaction_form_type: 4 | Footnotes: F1, F3, F1, F1

Footnotes:

• F1: Represents conversion of 10,732 restricted stock units ("RSUs") granted to the reporting person on October 13, 2025 into 10,732 shares of common stock of the Issuer on January 1, 2026.
• F2: These shares were sold to pay tax liability associated with the vesting of RSUs.
• F3: Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer.